48.24
Schlusskurs vom Vortag:
$47.62
Offen:
$47.64
24-Stunden-Volumen:
2.49M
Relative Volume:
1.31
Marktkapitalisierung:
$9.02B
Einnahmen:
$29.52M
Nettoeinkommen (Verlust:
$-567.06M
KGV:
-13.18
EPS:
-3.66
Netto-Cashflow:
$-551.11M
1W Leistung:
+3.28%
1M Leistung:
+19.26%
6M Leistung:
+43.27%
1J Leistung:
-2.55%
Revolution Medicines Inc Stock (RVMD) Company Profile
Firmenname
Revolution Medicines Inc
Sektor
Branche
Telefon
415-766-3638
Adresse
700 SAGINAW DR, REDWOOD CITY, CA
Vergleichen Sie RVMD mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
RVMD
Revolution Medicines Inc
|
48.24 | 8.90B | 29.52M | -567.06M | -551.11M | -3.66 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Revolution Medicines Inc Stock (RVMD) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-09-12 | Fortgesetzt | Raymond James | Strong Buy |
2025-09-05 | Eingeleitet | Truist | Buy |
2025-08-19 | Eingeleitet | Piper Sandler | Overweight |
2025-08-15 | Eingeleitet | Wells Fargo | Overweight |
2025-07-15 | Eingeleitet | Goldman | Buy |
2024-07-16 | Bestätigt | Needham | Buy |
2024-07-12 | Eingeleitet | Barclays | Overweight |
2024-07-08 | Eingeleitet | Jefferies | Buy |
2024-04-12 | Bestätigt | Needham | Buy |
2024-04-10 | Hochstufung | Raymond James | Outperform → Strong Buy |
2024-03-11 | Eingeleitet | Piper Sandler | Overweight |
2024-01-05 | Hochstufung | BofA Securities | Neutral → Buy |
2024-01-04 | Eingeleitet | Wedbush | Outperform |
2023-11-16 | Eingeleitet | Raymond James | Outperform |
2023-02-28 | Hochstufung | JP Morgan | Neutral → Overweight |
2022-12-14 | Eingeleitet | Needham | Buy |
2022-10-21 | Eingeleitet | Oppenheimer | Outperform |
2022-05-20 | Eingeleitet | BofA Securities | Neutral |
2022-03-01 | Hochstufung | Stifel | Hold → Buy |
2021-09-23 | Eingeleitet | Stifel | Hold |
2021-08-12 | Herabstufung | Goldman | Buy → Neutral |
2021-05-18 | Eingeleitet | Goldman | Buy |
2020-05-21 | Eingeleitet | H.C. Wainwright | Buy |
2020-03-09 | Eingeleitet | Cowen | Outperform |
2020-03-09 | Eingeleitet | Guggenheim | Buy |
2020-03-09 | Eingeleitet | JP Morgan | Neutral |
Alle ansehen
Revolution Medicines Inc Aktie (RVMD) Neueste Nachrichten
What recovery options are there for Revolution Medicines Inc.2025 AllTime Highs & Detailed Earnings Play Alerts - newser.com
Can technical indicators confirm Revolution Medicines Inc.’s reversalTrade Exit Summary & AI Powered Buy/Sell Recommendations - newser.com
Why Revolution Medicines Inc. Equity Warrant stock appeals to dividend seekersOptions Play & Long-Term Capital Growth Ideas - newser.com
Using data models to predict Revolution Medicines Inc. stock movementQuarterly Profit Review & Real-Time Buy Signal Notifications - newser.com
Should you wait for a breakout in Revolution Medicines Inc. Equity WarrantGap Up & Community Shared Stock Ideas - newser.com
How high can Revolution Medicines Inc. Equity Warrant stock goMarket Activity Summary & Technical Entry and Exit Alerts - newser.com
How Revolution Medicines Inc. stock performs in interest rate cycles2025 Volume Leaders & Verified Momentum Stock Watchlist - newser.com
Revolution Medicines Inc. Equity Warrant stock volume spike explained2025 Volume Leaders & High Conviction Investment Ideas - newser.com
How analysts revise price targets for Revolution Medicines Inc. (42Z) stockJuly 2025 Market Mood & Community Consensus Stock Picks - newser.com
What recovery options are there for Revolution Medicines Inc. Equity WarrantQuarterly Portfolio Summary & Low Volatility Stock Recommendations - newser.com
Revolution Medicines’ SWOT analysis: RAS inhibitor stock poised for growth amid fierce competition - Investing.com India
Revolution Medicines’ SWOT analysis: RAS inhibitor stock poised for growth amid fierce competition By Investing.com - Investing.com South Africa
What analysts say about Revolution Medicines Inc stockTrendline Breakouts & Explosive Growth Opportunities - earlytimes.in
Did Leadership Moves Just Shift Revolution Medicines' (RVMD) Investment Narrative Ahead of Key Launches? - Yahoo
Is now a turning point for Revolution Medicines Inc. Equity WarrantJuly 2025 Spike Watch & Low Volatility Stock Recommendations - newser.com
Assessing Revolution Medicines After Recent Cancer Breakthrough and 15% Monthly Rally - Yahoo Finance
Real time breakdown of Revolution Medicines Inc. stock performance2025 Technical Overview & Real-Time Stock Movement Alerts - newser.com
Using fundamentals and technicals on Revolution Medicines Inc. Equity WarrantTrade Signal Summary & Daily Profit Maximizing Tips - newser.com
How hedge fund analytics apply to Revolution Medicines Inc. stockQuarterly Earnings Report & Risk Managed Investment Entry Signals - newser.com
Short interest data insights for Revolution Medicines Inc.Weekly Investment Summary & High Accuracy Swing Trade Signals - newser.com
Evaluating Revolution Medicines Inc. with trendline analysisPortfolio Return Report & Stock Portfolio Risk Management - newser.com
Multi factor analysis applied to Revolution Medicines Inc. Equity WarrantTreasury Yields & Proven Capital Preservation Tips - newser.com
Will Revolution Medicines Inc. stock go up soon2025 Retail Activity & Weekly High Momentum Picks - newser.com
Will Revolution Medicines Inc. Equity Warrant stock benefit from upcoming earnings reportsBreakout Watch & Risk Controlled Stock Pick Alerts - newser.com
Advanced analytics toolkit walkthrough for Revolution Medicines Inc. Equity WarrantMarket Sentiment Review & Real-Time Stock Price Movement Reports - newser.com
Will Revolution Medicines Inc. Equity Warrant price bounce be sustainable2025 Top Gainers & Reliable Price Breakout Alerts - newser.com
Is Revolution Medicines Inc. stock vulnerable to regulatory risksSwing Trade & Reliable Volume Spike Trade Alerts - newser.com
Long term hold vs stop loss in Revolution Medicines Inc. Equity WarrantMarket Risk Analysis & Growth Oriented Trade Recommendations - newser.com
Published on: 2025-10-05 02:52:08 - newser.com
Will Revolution Medicines Inc. Equity Warrant outperform the marketEarnings Beat & Weekly High Conviction Trade Ideas - newser.com
Sentiment analysis tools applied to Revolution Medicines Inc.Market Trend Summary & Verified Entry Point Detection - newser.com
Regression analysis insights on Revolution Medicines Inc. Equity Warrant performanceWeekly Trading Summary & Risk Managed Investment Strategies - newser.com
What moving averages say about Revolution Medicines Inc.Trend Reversal & Low Volatility Stock Recommendations - newser.com
Published on: 2025-10-03 01:48:18 - newser.com
Using RSI to spot recovery in Revolution Medicines Inc.2025 Market Trends & Fast Entry High Yield Stock Tips - newser.com
Finanzdaten der Revolution Medicines Inc-Aktie (RVMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):